Hematology

Filter

Physical Function Scores Help Predict Outcomes in Multiple Myeloma Treatment

July 2025

A new study finds that how patients feel and function before starting treatment can help predict how well they’ll respond to multiple myeloma therapies.

EMJ

Virtual Blood Could Be the Key to More Effective Treatments for Blood Cancers

DEVELOPMENT of treatments for leukaemia and lymphoma could be aided by a new computer model that simulates the development of blood cells…

EMJ

New Treatment Option for CLL Patients with Poorest Prognosis

Patients with a particularly difficult-to-treat form of chronic lymphocytic leukaemia have gained access to a new treatment option in the US…

EMJ

IMBRUVICA™ (Ibrutinib) Now Approved in the u.s. For Patients with Chronic Lymphocytic Leukemia Who Have Received at Least One Prior Therapy

HORSHAM, PA, February 12, 2014 – Janssen Biotech, Inc. [“Janssen”] today announced the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA™…

Loading posts...

« Previous 1 … 35 36 37